跳至主要内容
临床试验/NCT05554640
NCT05554640已完成不适用

Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses

Johnson & Johnson Vision Care, Inc.2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2022年10月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Proportion of Eyes With Acceptable Lens Fitting

研究概览

简要总结

This is a subject-masked, randomized, bilateral, 2x2 crossover clinical investigation that will assess lens fit acceptance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • Between 18 and 40 (inclusive) years of age at the time of screening.
  • They agree not to participate in other clinical research while enrolled on this study.
  • They have worn the same brand of soft daily disposable silicone hydrogel contact lenses at least eight hours per day for at least four days per week over the past 4 weeks.
  • They own a wearable pair of spectacles if needed for distance vision correction (by self-report).
  • They can attain a best-corrected logMAR distance visual acuity of at least 0.20 in each eye.
  • They have spherical contact lens prescription in the range -1.00 to -6.00 DS (based on the calculated ocular refraction).
  • They have up to maximum of 1.00 DC of refractive astigmatism (based on the calculated ocular refraction).

排除标准

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Currently pregnant or lactating.
  • Any systemic disease (e.g., Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g., rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study or may pose a risk to study personnel.
  • They have an ocular disorder which would normally contraindicate contact lens wear.
  • They have had cataract surgery.
  • They have had corneal refractive surgery.
  • They are using any topical medications such as eye drops or ointments.
  • Any known hypersensitivity or allergic reaction to sodium fluorescein.
  • Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear. See section 9.1 for additional details regarding excluded systemic medications.
  • Participation in any contact lens or lens care product clinical trial within 2 weeks prior to study enrollment.
  • Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • Any Efron Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection),
  • They have a pre-corneal tear film break-up time less than five seconds when evaluated on the DESMD tear film imaging system.

结局指标

主要结局

Proportion of Eyes With Acceptable Lens Fitting

时间窗: Up to 2-Week Follow-up

Contact lens fitting acceptance was assessed for each subject eye using a biomicroscope post lens insertion, the 1- and 2-week follow-up evaluations and any unscheduled visits. Lens fit was a binary variable where acceptable lens fit=1 and unacceptable lens fit=0. The proportion of eyes with acceptable lens fit was reported.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验